This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $102.26, marking a +1.57% move from the previous day.
The Zacks Analyst Blog Highlights Microsoft, CVS Health, Lockheed Martin, Berkshire Hathaway and Mitsubishi UFJ Financial Group
by Zacks Equity Research
Microsoft, CVS Health, Lockheed Martin, Berkshire Hathaway, and Mitsubishi UFJ Financial Group are part of The Zacks top Analyst Blog.
Top Research Reports for Microsoft, CVS Health & Lockheed Martin
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), CVS Health (CVS) and Lockheed Martin (LMT).
Buckle (BKE) Benefits From Solid Sales & Online Business
by Zacks Equity Research
Buckle (BKE) reports higher sales and comparable store sales for August. BKE's men's and women's businesses continue to boost the top-line performance.
Company News for Sep 7, 2022
by Zacks Equity Research
Companies In The News Are: BBBY, SGFY, CVS, LOW, ILMN.
CVS Health (CVS) to Buy Signify Health, Grow in Home Healthcare
by Zacks Equity Research
According to CVS Health (CVS), Signify Health, as a leading healthcare platform, will play a critical role in advancing the company's healthcare services strategy.
Will Business Momentum Aid Home Depot (HD) Amid Cost Woes?
by Zacks Equity Research
Home Depot (HD) looks well-poised on strength in Pro & DIY categories, robust housing market trends, digital momentum and ongoing investments despite cost woes.
Signet (SIG) Q2 Earnings Beat Estimates, Sales Fall Y/Y
by Zacks Equity Research
Signet (SIG) delivers better-than-estimated second-quarter fiscal 2023 results. However, sales fall from the year-ago fiscal quarter's level due to weak same-store sales.
Why Is CVS Health (CVS) Down 1.9% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Big Lots' (BIG) Q2 Loss Narrower than Expected, Revenues Fall Y/Y
by Zacks Equity Research
Big Lots (BIG) reports a narrower-than-expected loss per share for second-quarter fiscal 2022. Also, comparable sales fall 9.2% in the quarter and hurt overall sales.
Best Buy's (BBY) Q2 Earnings Beat, Comparable Sales Fall 12.1%
by Zacks Equity Research
Best Buy (BBY) reports mixed second-quarter fiscal 2023 sales due to lower enterprise comparable sales.
J&J (JNJ) Gets EU Nod for Multiple Myeloma Drug Tecvayli
by Zacks Equity Research
J&J (JNJ) gets approval for Tecvayli (teclistamab) for the treatment of relapsed and refractory multiple myeloma. This marks the first approval for Tecvayli in any country.
Urban Outfitters (URBN) Q2 Earnings Miss, Sales Improve Y/Y
by Zacks Equity Research
Urban Outfitters' (URBN) second-quarter fiscal 2023 earnings results reflect inflationary pressures from inbound freight expenses and transportation costs.
UnitedHealth (UNH) Eyes Signify Health Acquisition: Here's Why
by Zacks Equity Research
UnitedHealth (UNH) is reportedly the highest bidder with more than $30 per share for Signify Health.
Foot Locker (FL) Stock Up 20% on Q2 Earnings & Sales Beat
by Zacks Equity Research
Foot Locker (FL) posts better-than-expected earnings for second-quarter fiscal 2022. FL's FLX membership program and omni-channel capabilities appear encouraging.
CVS Health (CVS) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
CVS Health (CVS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SpartanNash's (SPTN) Earnings Beat in Q2, Sales Rise Y/Y
by Zacks Equity Research
SpartanNash (SPTN) posts higher sales for the second quarter of 2022 on increased sales across all segments and solid comparable store sales.
This 1 Retail and Wholesale Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Lowe's (LOW) Q2 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Lowe's (LOW) reports a solid earnings performance for second-quarter fiscal 2022. A healthy operating margin backed by gains from the Total Home strategy aids the bottom line.
Home Depot (HD) Q2 Earnings Beat, Stock Down on Soft Margins
by Rajani Lohia
Home Depot's (HD) Q2 results reflect continued strong demand for home-improvement projects. HD's results represented the highest ever sales and earnings in its history.
The Zacks Analyst Blog Highlights Eli Lilly, CVS Health, Target, Chipotle Mexican Grill and FirstEnergy
by Zacks Equity Research
Eli Lilly, CVS Health, Target, Chipotle Mexican Grill and FirstEnergy are part of The Zacks top Analyst Blog.
Top Stock Reports for Eli Lilly, CVS Health & Target
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Eli Lilly and Company (LLY), CVS Health Corporation (CVS), and Target Corporation (TGT)
Has CVS Health (CVS) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Here is how CVS Health (CVS) and Dollar Tree (DLTR) have performed compared to their sector so far this year.
Stock Market News for Aug 4, 2022
by Zacks Equity Research
Wall Street closed sharply higher on Wednesday on the back of robust economic data and strong earnings numbers.
CVS Health (CVS) Q2 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
CVS Health (CVS) posts better-than-expected results in Q2, with robust performances across all operating segments driving the top line.